🔎 Trials Near Me

Home › Myelofibrosis › Maryland › Baltimore

Pag-aaral pangklinika para sa Myelofibrosis sa Baltimore, MD

Isang pag-aaral para sa Myelofibrosis ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Baltimore. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Bone Marrow or Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies

Nagre-recruitMaagang Phase 1
  • Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT06398457

A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis

Nagre-recruitPhase 1/2
  • University of Maryland, Baltimore
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT04176198

A Study to Evaluate INCA035784 in Participants With Myeloproliferative Neoplasms

Nagre-recruitPhase 1
  • Johns Hopkins University, Baltimore
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 6, 2026 · NCT07008118

Study of INCA036978 in Participants With Myeloproliferative Neoplasms

Nagre-recruitPhase 1
  • John Hopkins Hospital, Baltimore
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 22, 2026 · NCT07441694

A Study to Evaluate INCA033989 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasms

Nagre-recruitPhase 1
  • Johns Hopkins Hospital, Baltimore
Edad 18 pataas · Lahat ng kasarian · Na-update Abr 17, 2026 · NCT06034002

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Nagre-recruitObservasyonal na pag-aaral
  • Massive Bio SYNERGY-AI site, Baltimore
  • Massive Bio SYNERGY-AI site, Towson · 8 mi ang layo
Lahat ng edad · Lahat ng kasarian · Na-update Okt 28, 2025 · NCT03452774

Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib

Nagre-recruitPhase 3
  • Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore
Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2025 · NCT06479135

Pag-aaral para sa Myelofibrosis sa ibang lungsod

Iba pang pag-aaral sa Baltimore

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.